198
Participants
Start Date
April 30, 2015
Primary Completion Date
December 31, 2016
Study Completion Date
April 30, 2017
Methylnaltrexone (MNTX)
MNTX nearly 0.15mg/kg administered every other day for 2 weeks. Baseline laxatives and rescue laxative ( enemas/suppositories ) were allowed, but could not be administered within 4 hours of the study drug.
Placebo
Placebo administered every other day for 2 weeks. Baseline laxatives and rescue laxative ( enemas/suppositories ) were allowed, but could not be administered within 4 hours of the study drug.
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
RECRUITING
Xin Hua Hospital affiliated to Shanghai Jiao Tong University School of Medicine Chongming Branch, Shanghai
RECRUITING
The Affiliated Hospital of Xuzhou Medical College, Xuzhou
RECRUITING
The Second Hospital of Anhui Medical University, Hefei
RECRUITING
Linyi Cancer Hospital, Linyi
RECRUITING
Jiangxi Cancer Hospital, Nanchang
RECRUITING
Fujian Provincial cancer Hospital, Fuzhou
RECRUITING
Zhongnan Hospital of Wuhan University, Wuhan
RECRUITING
Henan Provincial Cancer Hospital, Zhengzhou
RECRUITING
Tumor Hospital of Yunnan Province The Third Affiliated Hospital of Kunming Medical University, Kunming
RECRUITING
Tangdu Hospital, Xian
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY